Prevalence of dysglycaemia in rural Andhra Pradesh - 2005, 2010, and 2014. Journal of Diabetes. 2015.
Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease. BMJ Open. 2015;5:e008018.
Progress in Medicine: Experts Take Stock. PLoS Medicine. 2015;12:e1001933.
Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. American Heart Journal. 2015;169:349-55.
The Effect of a Cardiovascular Polypill Strategy on Pill Burden. Cardiovascular Therapeutics. 2015;33(6).
A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluation. Implementation Science. 2014;9:187.
A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol. BMJ Open. 2014;4:e004523.
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial. Medical Journal of Australia. 2014;201:671-3.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591-8.
Do cardiac biomarkers NT-proBNP and hsTnT predict microvascular events in patients with type 2 diabetes? Results from the ADVANCE trial. Diabetes Care. 2014;37:2202-10.
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. Hypertension. 2014;63:259-64.
Globalisation and heart failure in the 21st Century [plenary speaker]. In: Bosch Institute Annual Symposium. Bosch Institute Annual Symposium. Sydney, Australia; 2014..
Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Medicine. 2014;11:e1001699.
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes. 2014;7(2):217-26. doi:10.1161/CIRCOUTCOMES.113.000526.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465-74. doi:10.1007/s00125-014-3369-7.
Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: A cluster randomized controlled trial. American Heart Journal. 2014;167:28-35.
Intensification of medication and glycaemic control among patients with type 2 diabetes – the ADVANCE trial. Diabetes, Obesity & Metabolism. 2014;16:426-32.
Rational and design of a stepped-wedge cluster randomised trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. American Heart Journal. 2014.
Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure. 2014;2:440-6.
SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India. JMIR Mhealth Uhealth. 2014;2:e54.
System barriers to the evidence-based care of acute coronary syndrome patients in China: a qualitative analysis. Circulation: Cardiovascular Quality and Outcomes. 2014;7(2):209-16.
Task shifting for non-communicable disease management in low and middle income countries - a systematic review. PLoS ONE. 2014;9:e103754.
The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus. International Journal of Cardiology. 2014;182C:244-249.